Overcoming NSCLC Resistance After Chemoimmunotherapy
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a post by Roberto Ferrara, Medical Oncologist and Researcher in Thoracic Oncology at Vita-Salute San Raffaele University on X, about an article by Martin Reck et al:
“Just in time for your Summer reading! An exquisite Review in Nature Reviews Clinical Oncology on the hot issue of tackling/overcoming primary/acquired resistance in NSCLC Algorithmic dissection of options, including biomarkers, ADCs, Bispecifics and combos with TT.
Kudos to Martin Reck, Solange Peters, Fabrice Barlesi and all authors.”
Quoting Roberto Ferrara’s post:
“Want to dive into patterns, biomarkers and strategies to overcome primary and acquired resistance to immunotherapy in lung cancer? Check out our review just published on Nature Reviews Clinical Oncology. A master piece from Martin Reck, Fabrice Barlesi and many other kols!”
Title: Treatment of NSCLC after chemoimmunotherapy – are we making headway?
Authors: Martin Reck, Nikolaj Frost, Solange Peters, Bernard A. Fox, Roberto Ferrara, Rajkumar Savai, Fabrice Barlesi
More posts featuring NSCLC on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023